The New Zealand share market was flat as stock prices found a new level after a barrage of market moving news over the past 10 days.

The New Zealand dollar leapt to a 20-month high as the market reversed its bet the Reserve Bank will cut the official cash rate into negative territory.

Investors today sold recently top-performing stocks in favour of those worst affected by the covid-19 pandemic as news of an effective covid-19 vaccine prompted a massive rotation.

The kiwi dollar climbed to an 18-month high and New Zealand’s benchmark equity index closed at a new record as risk assets rallied in the wake of the US election results.

Synlait Milk led the local share market higher in the third day of a post-US election global equity rally as investors celebrated having some uncertainty behind them.

New Zealand’s main share index gained almost half a percent and the kiwi dollar lifted almost 1 US cent, as investors found enough political certainty in the US Senate result to look past the still undecided presidential race.

The New Zealand dollar reversed early gains as a path for a decisive Democratic win in the US election faded as incumbent President Donald Trump pulled ahead in Florida leaving the race too close to call.

The New Zealand share market rallied with its Australian counterpart as the Reserve Bank of Australia cut interest rates and expanded its quantitative easing program.

New Zealand shares edged lower as many investors fixated on the potential for civil unrest and a contested result following the United States presidential election on Wednesday.

New Zealand's headline share index fell today as ongoing coronavirus fears and end-of-month profit taking - notably Fisher & Paykel Healthcare - pushed the market down.

AMP’s KiwiSaver is still the worst-performing default provider as the deadline to bid for the next seven-year contract creeps closer.

New Zealand shares joined a worldwide rout as Europe’s return to lockdown reminded investors the pandemic still poses a serious threat to the global economy.

A share price bounce for Fisher & Paykel Healthcare helped inch the S&P/NZX 50 index higher today as a resurgence of covid-19 in the United States and Europe weighed on some stocks.

Fisher & Paykel Healthcare was weighed down by a stronger kiwi dollar while the rest of the market was knocked about by uncertainty over the US election and latest surge in covid-19 infections.

New Zealand's main share index rose half a percent today, closing out a week of muted trading.

New Zealand shares edged lower as global investor sentiment weakened.